Literature DB >> 15878060

Vitreous levels of vascular endothelial growth factor and intercellular adhesion molecule 1 are related to diabetic macular edema.

Hideharu Funatsu1, Hidetoshi Yamashita, Kumi Sakata, Hidetaka Noma, Tatsuya Mimura, Motohiro Suzuki, Shuichiro Eguchi, Sadao Hori.   

Abstract

PURPOSE: To investigate whether vascular endothelial growth factor (VEGF) or soluble intercellular adhesion molecule 1 (sICAM-1) is related to diabetic macular edema (DME).
DESIGN: Retrospective case-control study. PARTICIPANTS: Thirty-three patients who had DME and 13 patients with nondiabetic ocular disease (control group).
METHODS: Vitreous fluid samples were obtained at the time of vitreoretinal surgery, and the VEGF and sICAM-1 levels in vitreous fluid and plasma were measured by enzyme-linked immunosorbent assay. MAIN OUTCOME MEASURES: Relationship between vitreous levels of VEGF or sICAM-1 and DME.
RESULTS: Vitreous levels of VEGF and sICAM-1 were significantly higher in DME patients than in control patients (P < 0.0001 and P = 0.0004, respectively). The vitreous level of VEGF was significantly correlated with that of sICAM-1 (P < 0.0001). Vitreous levels of both VEGF and sICAM-1 were significantly higher in patients with hyperfluorescent DME than in those with minimally fluorescent DME (P = 0.0027 and P = 0.0005, respectively). The vitreous levels of both VEGF and sICAM-1 were significantly correlated with retinal thickness at the central fovea (P < 0.0001 and P = 0.0005, respectively)
CONCLUSIONS: We found that both VEGF and sICAM-1 were elevated in the vitreous fluid of patients with hyperfluorescent DME. These results suggest that VEGF and ICAM-1 are related to the increase of vascular permeability in DME patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15878060     DOI: 10.1016/j.ophtha.2004.11.045

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  65 in total

Review 1.  Angiogenesis in diabetes and obesity.

Authors:  Rui Cheng; Jian-xing Ma
Journal:  Rev Endocr Metab Disord       Date:  2015-03       Impact factor: 6.514

Review 2.  Immunological mechanisms in the pathogenesis of diabetic retinopathy.

Authors:  Anthony P Adamis; Adrienne J Berman
Journal:  Semin Immunopathol       Date:  2008-03-14       Impact factor: 9.623

3.  Is intravitreal bevacizumab treatment effective in diffuse diabetic macular edema?

Authors:  Sabine Biester; Focke Ziemssen; Karl Ulrich Bartz-Schmidt; Faik Gelisken
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-07-07       Impact factor: 3.117

4.  Effect of pyridone agent on blood-retinal barrier in diabetic mice.

Authors:  Si-Qi Xiong; Hai-Bo Jiang; Hui-Zhuo Xu; Xiao-Bo Xia
Journal:  Int J Ophthalmol       Date:  2017-06-18       Impact factor: 1.779

5.  Influence of baseline diabetic retinopathy status on initial anatomical response of intravitreal ranibizumab therapy for diabetic macular oedema.

Authors:  L Nicholson; N V Patrao; J Ramu; C Vazquez-Alfageme; M Muwas; R Rajendram; P G Hykin; S Sivaprasad
Journal:  Eye (Lond)       Date:  2017-04-28       Impact factor: 3.775

6.  Intravitreal vascular endothelial growth factor.

Authors:  Thomas Bertelmann; Stephan Schulze; Reka Bölöni; Walter Sekundo; Sebastian Irle; Thomas Stief; Stefan Mennel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-02-04       Impact factor: 3.117

7.  The diabetic ocular environment facilitates the development of endogenous bacterial endophthalmitis.

Authors:  Phillip S Coburn; Brandt J Wiskur; Elizabeth Christy; Michelle C Callegan
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-11-01       Impact factor: 4.799

8.  Proteolytic cleavage of vascular adhesion protein-1 induced by vascular endothelial growth factor in retinal capillary endothelial cells.

Authors:  Shiho Yoshida; Miyuki Murata; Kousuke Noda; Takashi Matsuda; Michiyuki Saito; Wataru Saito; Atsuhiro Kanda; Susumu Ishida
Journal:  Jpn J Ophthalmol       Date:  2018-02-01       Impact factor: 2.447

9.  Increase of aqueous inflammatory factors in macular edema with branch retinal vein occlusion: a case control study.

Authors:  Hidetaka Noma; Hideharu Funatsu; Tatsuya Mimura; Katsunori Shimada
Journal:  J Inflamm (Lond)       Date:  2010-08-26       Impact factor: 4.981

10.  Interfering ribonucleic acids that suppress expression of multiple unrelated genes.

Authors:  Toby Passioura; Mary M Gozar; Amber Goodchild; Andrew King; Greg M Arndt; Michael Poidinger; Donald J Birkett; Laurent P Rivory
Journal:  BMC Biotechnol       Date:  2009-06-16       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.